| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Local | 83 | 2018 | 985 | 8.640 |
Why?
|
| Lidocaine | 43 | 2018 | 544 | 4.920 |
Why?
|
| Endothelin-1 | 19 | 2018 | 314 | 4.630 |
Why?
|
| Hyperalgesia | 20 | 2017 | 502 | 3.940 |
Why?
|
| Bupivacaine | 27 | 2019 | 411 | 3.900 |
Why?
|
| Sciatic Nerve | 55 | 2020 | 607 | 3.760 |
Why?
|
| Pain, Postoperative | 22 | 2019 | 1643 | 3.610 |
Why?
|
| Nerve Block | 28 | 2020 | 644 | 2.700 |
Why?
|
| Sensory Receptor Cells | 11 | 2018 | 492 | 2.190 |
Why?
|
| Pain | 28 | 2018 | 4986 | 2.080 |
Why?
|
| Rats, Sprague-Dawley | 60 | 2020 | 8301 | 1.820 |
Why?
|
| Sodium Channels | 21 | 2015 | 349 | 1.660 |
Why?
|
| Touch | 7 | 2018 | 306 | 1.650 |
Why?
|
| Rats | 87 | 2020 | 24260 | 1.570 |
Why?
|
| Neural Conduction | 30 | 2009 | 440 | 1.480 |
Why?
|
| Anesthesia, Local | 8 | 2018 | 275 | 1.370 |
Why?
|
| Microspheres | 5 | 2015 | 777 | 1.330 |
Why?
|
| Nerve Growth Factor | 4 | 2018 | 149 | 1.300 |
Why?
|
| Analgesics | 8 | 2017 | 1040 | 1.270 |
Why?
|
| Ion Channels | 32 | 2008 | 1056 | 1.240 |
Why?
|
| Nociceptors | 11 | 2010 | 432 | 1.230 |
Why?
|
| Pain Measurement | 24 | 2020 | 3420 | 1.230 |
Why?
|
| Thoracotomy | 4 | 2017 | 363 | 1.220 |
Why?
|
| Pain Threshold | 10 | 2017 | 584 | 1.150 |
Why?
|
| Neurons, Afferent | 12 | 2010 | 506 | 1.150 |
Why?
|
| Sodium | 40 | 2008 | 1623 | 1.130 |
Why?
|
| Hindlimb | 8 | 2015 | 504 | 1.120 |
Why?
|
| Saxitoxin | 26 | 2015 | 65 | 1.100 |
Why?
|
| Receptor, Endothelin A | 9 | 2011 | 58 | 1.060 |
Why?
|
| Sodium Channel Blockers | 10 | 2016 | 176 | 1.020 |
Why?
|
| Skin | 13 | 2015 | 4364 | 0.980 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2016 | 200 | 0.960 |
Why?
|
| TRPV Cation Channels | 4 | 2016 | 236 | 0.910 |
Why?
|
| Animals | 173 | 2020 | 168757 | 0.800 |
Why?
|
| Peripheral Nerves | 5 | 2013 | 466 | 0.790 |
Why?
|
| Receptors, Endothelin | 8 | 2011 | 58 | 0.770 |
Why?
|
| Tachyphylaxis | 4 | 2010 | 51 | 0.720 |
Why?
|
| Peripheral Nervous System Diseases | 5 | 2008 | 685 | 0.720 |
Why?
|
| Veratridine | 7 | 2008 | 24 | 0.720 |
Why?
|
| Scorpion Venoms | 7 | 2004 | 31 | 0.670 |
Why?
|
| Docosahexaenoic Acids | 3 | 2017 | 875 | 0.670 |
Why?
|
| Receptors, Bradykinin | 1 | 2018 | 19 | 0.660 |
Why?
|
| Action Potentials | 44 | 2017 | 1806 | 0.650 |
Why?
|
| Receptor, Endothelin B | 4 | 2014 | 41 | 0.620 |
Why?
|
| Central Nervous System | 3 | 2010 | 1357 | 0.610 |
Why?
|
| Injections, Subcutaneous | 10 | 2018 | 666 | 0.600 |
Why?
|
| Receptors, Neurokinin-1 | 3 | 2017 | 129 | 0.590 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 2019 | 321 | 0.580 |
Why?
|
| Physical Stimulation | 7 | 2018 | 525 | 0.570 |
Why?
|
| Medulla Oblongata | 1 | 2017 | 243 | 0.540 |
Why?
|
| Receptor, trkA | 1 | 2016 | 164 | 0.530 |
Why?
|
| Membrane Potentials | 22 | 2009 | 1137 | 0.530 |
Why?
|
| Neurons, Efferent | 1 | 2015 | 82 | 0.520 |
Why?
|
| Behavior, Animal | 16 | 2013 | 1881 | 0.510 |
Why?
|
| Epinephrine | 7 | 2009 | 792 | 0.500 |
Why?
|
| Dose-Response Relationship, Drug | 26 | 2018 | 10943 | 0.500 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2015 | 697 | 0.490 |
Why?
|
| Potassium | 8 | 2009 | 1336 | 0.490 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2014 | 22 | 0.480 |
Why?
|
| Calcium | 12 | 2015 | 5756 | 0.480 |
Why?
|
| Endothelins | 3 | 2011 | 138 | 0.480 |
Why?
|
| Calcium Channels | 5 | 2008 | 622 | 0.480 |
Why?
|
| Conditioning, Operant | 1 | 2015 | 313 | 0.460 |
Why?
|
| Tetrodotoxin | 19 | 2004 | 259 | 0.460 |
Why?
|
| Spinal Cord | 3 | 2011 | 1809 | 0.450 |
Why?
|
| Calcium Channel Blockers | 3 | 2009 | 690 | 0.450 |
Why?
|
| Hot Temperature | 3 | 2016 | 1354 | 0.450 |
Why?
|
| Tetracaine | 3 | 2007 | 35 | 0.440 |
Why?
|
| Orosomucoid | 2 | 2003 | 45 | 0.430 |
Why?
|
| Delayed-Action Preparations | 5 | 2015 | 968 | 0.420 |
Why?
|
| Neurons | 20 | 2017 | 9338 | 0.420 |
Why?
|
| Morphine | 2 | 2015 | 657 | 0.410 |
Why?
|
| Surgical Mesh | 1 | 2014 | 276 | 0.400 |
Why?
|
| Rana pipiens | 20 | 2002 | 65 | 0.400 |
Why?
|
| Nerve Fibers, Myelinated | 15 | 2001 | 957 | 0.380 |
Why?
|
| Capsaicin | 5 | 2011 | 231 | 0.380 |
Why?
|
| Progesterone | 1 | 2015 | 776 | 0.380 |
Why?
|
| Type C Phospholipases | 1 | 2011 | 292 | 0.370 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2011 | 140 | 0.370 |
Why?
|
| Diterpenes | 2 | 2008 | 173 | 0.370 |
Why?
|
| Kinetics | 25 | 2013 | 6473 | 0.370 |
Why?
|
| Ganglia, Spinal | 7 | 2017 | 519 | 0.370 |
Why?
|
| Axons | 16 | 2020 | 1684 | 0.360 |
Why?
|
| Ion Channel Gating | 4 | 2002 | 437 | 0.360 |
Why?
|
| Procaine | 4 | 2004 | 60 | 0.360 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 2009 | 3 | 0.350 |
Why?
|
| Nerve Fibers | 15 | 2002 | 687 | 0.350 |
Why?
|
| Evoked Potentials | 2 | 2015 | 1056 | 0.350 |
Why?
|
| Anesthesia, Spinal | 5 | 2007 | 269 | 0.340 |
Why?
|
| Batrachotoxins | 6 | 1999 | 6 | 0.340 |
Why?
|
| Time Factors | 25 | 2019 | 40075 | 0.340 |
Why?
|
| Heart Arrest | 1 | 2019 | 1470 | 0.330 |
Why?
|
| Pituitary Gland, Anterior | 2 | 1999 | 177 | 0.330 |
Why?
|
| Polyradiculopathy | 1 | 2008 | 23 | 0.320 |
Why?
|
| Rana catesbeiana | 13 | 2009 | 86 | 0.320 |
Why?
|
| Protein Kinase C | 4 | 2017 | 1227 | 0.320 |
Why?
|
| Neuralgia | 4 | 2006 | 570 | 0.310 |
Why?
|
| Analysis of Variance | 7 | 2015 | 6365 | 0.310 |
Why?
|
| Membranes, Artificial | 3 | 2007 | 378 | 0.310 |
Why?
|
| Drug Implants | 4 | 2014 | 244 | 0.310 |
Why?
|
| Potassium Channels | 4 | 2003 | 563 | 0.300 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 2007 | 26 | 0.300 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 2007 | 43 | 0.300 |
Why?
|
| Peripheral Nervous System | 2 | 2007 | 150 | 0.300 |
Why?
|
| Adjuvants, Anesthesia | 2 | 2013 | 57 | 0.300 |
Why?
|
| Disease Models, Animal | 11 | 2017 | 18029 | 0.290 |
Why?
|
| Male | 70 | 2020 | 350118 | 0.290 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 625 | 0.290 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2009 | 306 | 0.290 |
Why?
|
| Analgesia | 5 | 2020 | 461 | 0.290 |
Why?
|
| Neurosecretory Systems | 1 | 2008 | 231 | 0.290 |
Why?
|
| Cytoplasm | 1 | 2011 | 1539 | 0.280 |
Why?
|
| Ions | 1 | 2007 | 265 | 0.270 |
Why?
|
| Motor Neurons | 5 | 2010 | 844 | 0.270 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2009 | 365 | 0.270 |
Why?
|
| Cell Membrane | 19 | 2004 | 3748 | 0.260 |
Why?
|
| Ranvier's Nodes | 5 | 1991 | 19 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2018 | 3309 | 0.250 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2009 | 895 | 0.250 |
Why?
|
| Mollusk Venoms | 3 | 1991 | 19 | 0.250 |
Why?
|
| Electric Stimulation | 14 | 2002 | 1767 | 0.240 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 331 | 0.240 |
Why?
|
| Receptors, Growth Factor | 2 | 2016 | 334 | 0.240 |
Why?
|
| Anesthesiology | 3 | 2014 | 1060 | 0.230 |
Why?
|
| Hydrogen-Ion Concentration | 16 | 2003 | 2557 | 0.230 |
Why?
|
| Glutamic Acid | 1 | 2009 | 1169 | 0.230 |
Why?
|
| Anesthesia | 1 | 2015 | 1561 | 0.230 |
Why?
|
| Injections, Spinal | 2 | 2017 | 303 | 0.230 |
Why?
|
| Amides | 2 | 2003 | 459 | 0.230 |
Why?
|
| Anesthetics, Inhalation | 3 | 2003 | 570 | 0.230 |
Why?
|
| Hair Follicle | 1 | 2005 | 209 | 0.230 |
Why?
|
| Adrenergic alpha-Agonists | 3 | 2009 | 177 | 0.220 |
Why?
|
| Vasoconstrictor Agents | 3 | 2003 | 642 | 0.220 |
Why?
|
| Patch-Clamp Techniques | 6 | 2016 | 964 | 0.210 |
Why?
|
| Stereoisomerism | 8 | 2002 | 624 | 0.210 |
Why?
|
| Molecular Conformation | 2 | 2002 | 563 | 0.210 |
Why?
|
| Sciatica | 1 | 2002 | 98 | 0.200 |
Why?
|
| Signal Transduction | 5 | 2018 | 23403 | 0.200 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 1526 | 0.200 |
Why?
|
| Cells, Cultured | 13 | 2017 | 19229 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1790 | 0.190 |
Why?
|
| Heart | 5 | 2006 | 4467 | 0.190 |
Why?
|
| Substance P | 4 | 2015 | 335 | 0.190 |
Why?
|
| Sodium Bicarbonate | 1 | 2000 | 62 | 0.190 |
Why?
|
| Detergents | 2 | 2004 | 230 | 0.180 |
Why?
|
| Cryotherapy | 1 | 2020 | 155 | 0.170 |
Why?
|
| Ice | 1 | 2020 | 104 | 0.170 |
Why?
|
| Binding, Competitive | 8 | 2004 | 1157 | 0.170 |
Why?
|
| Emulsions | 1 | 2019 | 156 | 0.160 |
Why?
|
| Muscles | 6 | 1986 | 1614 | 0.160 |
Why?
|
| Formaldehyde | 2 | 2010 | 353 | 0.160 |
Why?
|
| Peptides, Cyclic | 4 | 2010 | 400 | 0.160 |
Why?
|
| Spinal Nerves | 3 | 2015 | 86 | 0.160 |
Why?
|
| Functional Laterality | 4 | 2010 | 2290 | 0.160 |
Why?
|
| Protein Binding | 3 | 2018 | 9386 | 0.160 |
Why?
|
| Bradykinin | 1 | 2018 | 214 | 0.160 |
Why?
|
| Hair | 2 | 2013 | 483 | 0.160 |
Why?
|
| Binding Sites | 19 | 2004 | 6114 | 0.160 |
Why?
|
| Synaptic Transmission | 4 | 2010 | 1178 | 0.160 |
Why?
|
| Drug Synergism | 8 | 2003 | 1792 | 0.160 |
Why?
|
| Toxins, Biological | 3 | 1987 | 66 | 0.150 |
Why?
|
| Naloxone | 3 | 2010 | 367 | 0.150 |
Why?
|
| 4-Aminopyridine | 2 | 2002 | 81 | 0.150 |
Why?
|
| Myelin Sheath | 4 | 2020 | 652 | 0.150 |
Why?
|
| Fluorescent Dyes | 3 | 2003 | 1917 | 0.150 |
Why?
|
| Rabbits | 15 | 1999 | 4894 | 0.150 |
Why?
|
| Chemical Phenomena | 6 | 2003 | 518 | 0.150 |
Why?
|
| Vagus Nerve | 6 | 1991 | 438 | 0.150 |
Why?
|
| Electrophysiology | 8 | 2001 | 1308 | 0.150 |
Why?
|
| Indole Alkaloids | 1 | 2016 | 24 | 0.150 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 4933 | 0.150 |
Why?
|
| Benzylidene Compounds | 1 | 2016 | 27 | 0.140 |
Why?
|
| Pregnancy, Animal | 1 | 1997 | 134 | 0.140 |
Why?
|
| Solutions | 5 | 2003 | 426 | 0.140 |
Why?
|
| Tosyl Compounds | 2 | 1987 | 113 | 0.140 |
Why?
|
| Proprioception | 3 | 2003 | 132 | 0.140 |
Why?
|
| Foot | 2 | 2010 | 527 | 0.140 |
Why?
|
| Chloride Channels | 2 | 1994 | 227 | 0.140 |
Why?
|
| Anesthesia, Conduction | 1 | 2019 | 238 | 0.140 |
Why?
|
| Cnidarian Venoms | 2 | 2002 | 19 | 0.130 |
Why?
|
| Catastrophization | 1 | 2019 | 316 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 1622 | 0.130 |
Why?
|
| Oxytocin | 1 | 2019 | 394 | 0.130 |
Why?
|
| Affinity Labels | 1 | 1995 | 109 | 0.130 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 1420 | 0.130 |
Why?
|
| Cell Line | 5 | 2018 | 15997 | 0.130 |
Why?
|
| Drug Interactions | 4 | 2004 | 1460 | 0.130 |
Why?
|
| Carbazoles | 1 | 2016 | 226 | 0.130 |
Why?
|
| Azides | 1 | 1995 | 116 | 0.130 |
Why?
|
| Arthralgia | 1 | 2019 | 456 | 0.130 |
Why?
|
| Medical Illustration | 1 | 2015 | 133 | 0.130 |
Why?
|
| Drug Delivery Systems | 3 | 2017 | 2219 | 0.130 |
Why?
|
| Mechanoreceptors | 1 | 1996 | 186 | 0.120 |
Why?
|
| Injections | 2 | 2020 | 840 | 0.120 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2015 | 130 | 0.120 |
Why?
|
| Sphingosine | 1 | 2016 | 307 | 0.120 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2015 | 141 | 0.120 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2014 | 68 | 0.120 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 970 | 0.120 |
Why?
|
| Thermoreceptors | 1 | 1994 | 27 | 0.120 |
Why?
|
| Radiculopathy | 1 | 1996 | 197 | 0.120 |
Why?
|
| Lipids | 3 | 2019 | 3305 | 0.120 |
Why?
|
| Antibody Affinity | 1 | 2014 | 254 | 0.120 |
Why?
|
| Micelles | 1 | 1994 | 203 | 0.120 |
Why?
|
| Mastectomy | 2 | 2019 | 1793 | 0.120 |
Why?
|
| Amines | 1 | 2015 | 276 | 0.120 |
Why?
|
| Ribs | 1 | 2015 | 252 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2014 | 4204 | 0.110 |
Why?
|
| Astrocytes | 3 | 2014 | 1270 | 0.110 |
Why?
|
| Afferent Pathways | 2 | 1994 | 302 | 0.110 |
Why?
|
| Neoplasms | 2 | 2015 | 21683 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 3 | 2016 | 4462 | 0.110 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 725 | 0.110 |
Why?
|
| Guanfacine | 1 | 1993 | 51 | 0.110 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 503 | 0.110 |
Why?
|
| Air | 1 | 2013 | 182 | 0.110 |
Why?
|
| Brain | 10 | 2014 | 26385 | 0.110 |
Why?
|
| Synaptosomes | 4 | 1995 | 115 | 0.110 |
Why?
|
| Antibody Specificity | 1 | 2014 | 1095 | 0.110 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1991 | 32 | 0.110 |
Why?
|
| Clonidine | 1 | 1993 | 164 | 0.110 |
Why?
|
| Peptides | 4 | 2006 | 4409 | 0.100 |
Why?
|
| Estradiol | 1 | 1999 | 2020 | 0.100 |
Why?
|
| Adsorption | 2 | 2007 | 201 | 0.100 |
Why?
|
| Chemistry, Physical | 3 | 2003 | 156 | 0.100 |
Why?
|
| Aniline Compounds | 1 | 2016 | 986 | 0.100 |
Why?
|
| Methyl Ethers | 2 | 2003 | 205 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 3798 | 0.100 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2010 | 281 | 0.100 |
Why?
|
| Amiloride | 1 | 1991 | 121 | 0.100 |
Why?
|
| Research Design | 2 | 2004 | 5987 | 0.100 |
Why?
|
| Transdermal Patch | 1 | 2011 | 51 | 0.100 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2013 | 247 | 0.100 |
Why?
|
| Connexins | 1 | 2013 | 357 | 0.100 |
Why?
|
| Bufo marinus | 5 | 1990 | 32 | 0.100 |
Why?
|
| Amitriptyline | 1 | 2011 | 110 | 0.100 |
Why?
|
| Structure-Activity Relationship | 7 | 2003 | 3129 | 0.100 |
Why?
|
| Olfactory Nerve | 5 | 1984 | 22 | 0.090 |
Why?
|
| Humans | 38 | 2019 | 744343 | 0.090 |
Why?
|
| Cesarean Section | 1 | 2019 | 1365 | 0.090 |
Why?
|
| Inflammation | 2 | 2011 | 10638 | 0.090 |
Why?
|
| Thiophenes | 1 | 2015 | 588 | 0.090 |
Why?
|
| Chloramines | 2 | 1987 | 14 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 964 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 813 | 0.090 |
Why?
|
| Keratinocytes | 2 | 2013 | 798 | 0.090 |
Why?
|
| Nephropidae | 4 | 1986 | 71 | 0.090 |
Why?
|
| Ligation | 2 | 2003 | 453 | 0.090 |
Why?
|
| Arthroplasty | 1 | 2013 | 305 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2008 | 1222 | 0.090 |
Why?
|
| Narcotic Antagonists | 2 | 2009 | 562 | 0.090 |
Why?
|
| Anesthetics | 2 | 2010 | 539 | 0.090 |
Why?
|
| Time | 1 | 2011 | 542 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2003 | 689 | 0.090 |
Why?
|
| Nerve Compression Syndromes | 2 | 2003 | 160 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2008 | 1889 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2726 | 0.090 |
Why?
|
| Nimodipine | 1 | 2009 | 55 | 0.090 |
Why?
|
| Versicans | 1 | 2009 | 33 | 0.090 |
Why?
|
| Cells | 1 | 2011 | 168 | 0.090 |
Why?
|
| Veratrine | 3 | 1986 | 6 | 0.090 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2009 | 29 | 0.090 |
Why?
|
| Breast | 1 | 2018 | 1969 | 0.090 |
Why?
|
| Mice | 8 | 2018 | 81183 | 0.090 |
Why?
|
| Fluorescence | 2 | 2007 | 751 | 0.090 |
Why?
|
| Depression, Chemical | 4 | 1999 | 191 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 1121 | 0.080 |
Why?
|
| Receptors, Opioid | 1 | 2009 | 155 | 0.080 |
Why?
|
| Cell Size | 2 | 2009 | 643 | 0.080 |
Why?
|
| Forecasting | 1 | 2018 | 2951 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2373 | 0.080 |
Why?
|
| Osteoarthritis, Knee | 1 | 2019 | 1222 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2019 | 2585 | 0.080 |
Why?
|
| Anesthesia, Epidural | 2 | 2007 | 228 | 0.080 |
Why?
|
| Antibodies | 1 | 2016 | 2460 | 0.080 |
Why?
|
| Cardiac Glycosides | 1 | 1988 | 30 | 0.080 |
Why?
|
| Electric Conductivity | 6 | 1991 | 411 | 0.080 |
Why?
|
| Myocardium | 4 | 2006 | 4776 | 0.080 |
Why?
|
| Chlorides | 1 | 1991 | 667 | 0.080 |
Why?
|
| Acetanilides | 1 | 1989 | 168 | 0.080 |
Why?
|
| Reaction Time | 4 | 2006 | 2097 | 0.080 |
Why?
|
| Sandhoff Disease | 1 | 2007 | 13 | 0.080 |
Why?
|
| Reflex | 2 | 2000 | 365 | 0.080 |
Why?
|
| Schools, Medical | 1 | 2014 | 880 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 1458 | 0.080 |
Why?
|
| Calcium Channels, L-Type | 1 | 2009 | 240 | 0.080 |
Why?
|
| Epitopes | 1 | 2014 | 2571 | 0.080 |
Why?
|
| Aeromonas | 1 | 1987 | 14 | 0.080 |
Why?
|
| Tetraethylammonium | 2 | 2001 | 58 | 0.080 |
Why?
|
| Ethanolamines | 1 | 1988 | 158 | 0.080 |
Why?
|
| Hyperesthesia | 1 | 2007 | 17 | 0.080 |
Why?
|
| Receptors, Cholinergic | 1 | 1988 | 238 | 0.080 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 502 | 0.080 |
Why?
|
| Cell Membrane Permeability | 2 | 1988 | 590 | 0.080 |
Why?
|
| Ultrasonic Therapy | 1 | 2009 | 235 | 0.070 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 582 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 1678 | 0.070 |
Why?
|
| Cartilage Diseases | 1 | 2008 | 160 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 452 | 0.070 |
Why?
|
| Conotoxins | 1 | 1986 | 20 | 0.070 |
Why?
|
| Lectins | 1 | 2009 | 513 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2014 | 5179 | 0.070 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1991 | 789 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 2025 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2015 | 2250 | 0.070 |
Why?
|
| Acrylamides | 1 | 1988 | 255 | 0.070 |
Why?
|
| Skin Temperature | 2 | 1997 | 93 | 0.070 |
Why?
|
| Solubility | 5 | 2009 | 1085 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2006 | 148 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 1525 | 0.070 |
Why?
|
| Imidazoles | 1 | 2011 | 1206 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2016 | 425 | 0.060 |
Why?
|
| Skin Physiological Phenomena | 2 | 1997 | 180 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2006 | 821 | 0.060 |
Why?
|
| Sulfites | 1 | 2004 | 79 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6622 | 0.060 |
Why?
|
| Receptors, Tachykinin | 2 | 1994 | 25 | 0.060 |
Why?
|
| Motor Activity | 3 | 2003 | 2714 | 0.060 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2006 | 211 | 0.060 |
Why?
|
| Buffers | 3 | 1990 | 147 | 0.060 |
Why?
|
| Ranidae | 2 | 1995 | 33 | 0.060 |
Why?
|
| Models, Biological | 8 | 2009 | 9583 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2015 | 8436 | 0.060 |
Why?
|
| Calcium Signaling | 2 | 2006 | 721 | 0.060 |
Why?
|
| Guanidines | 3 | 1993 | 193 | 0.060 |
Why?
|
| Pharmaceutical Solutions | 1 | 2003 | 15 | 0.060 |
Why?
|
| Mathematics | 4 | 1990 | 728 | 0.060 |
Why?
|
| Isoflurane | 2 | 2002 | 380 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 491 | 0.060 |
Why?
|
| Carbon Dioxide | 2 | 1993 | 1150 | 0.060 |
Why?
|
| Nerve Regeneration | 2 | 2000 | 788 | 0.060 |
Why?
|
| Sodium Chloride | 2 | 1999 | 625 | 0.060 |
Why?
|
| Microglia | 1 | 2011 | 1266 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2716 | 0.060 |
Why?
|
| Spectrophotometry | 2 | 2001 | 313 | 0.060 |
Why?
|
| Chick Embryo | 3 | 1991 | 982 | 0.050 |
Why?
|
| Pituitary Gland | 2 | 2016 | 665 | 0.050 |
Why?
|
| Cell Movement | 1 | 2015 | 5217 | 0.050 |
Why?
|
| Neural Inhibition | 2 | 2004 | 602 | 0.050 |
Why?
|
| Surface Properties | 2 | 2003 | 1184 | 0.050 |
Why?
|
| Orthopedic Procedures | 1 | 2013 | 1288 | 0.050 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2003 | 150 | 0.050 |
Why?
|
| Anesthesia, General | 2 | 1988 | 1171 | 0.050 |
Why?
|
| Age Factors | 2 | 2019 | 18370 | 0.050 |
Why?
|
| Chemistry | 3 | 1987 | 352 | 0.050 |
Why?
|
| Infusions, Intravenous | 2 | 2006 | 2274 | 0.050 |
Why?
|
| Potassium Channel Blockers | 1 | 2002 | 171 | 0.050 |
Why?
|
| Decapodiformes | 4 | 1987 | 33 | 0.050 |
Why?
|
| Benz(a)Anthracenes | 1 | 2001 | 12 | 0.050 |
Why?
|
| Deuterium | 1 | 1981 | 101 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 203 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2282 | 0.050 |
Why?
|
| Spinal Nerve Roots | 1 | 2001 | 121 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 1986 | 5021 | 0.050 |
Why?
|
| Sex Factors | 1 | 2015 | 10397 | 0.050 |
Why?
|
| Administration, Cutaneous | 2 | 2015 | 711 | 0.050 |
Why?
|
| Cartilage, Articular | 1 | 2008 | 1095 | 0.050 |
Why?
|
| Sodium Hydroxide | 1 | 2000 | 44 | 0.050 |
Why?
|
| Guanidine | 2 | 1993 | 33 | 0.050 |
Why?
|
| Phloretin | 1 | 1980 | 17 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2009 | 2263 | 0.050 |
Why?
|
| Carbon Radioisotopes | 2 | 1997 | 577 | 0.050 |
Why?
|
| Algorithms | 3 | 2010 | 13881 | 0.050 |
Why?
|
| Sympathomimetics | 1 | 2000 | 57 | 0.050 |
Why?
|
| 1-Octanol | 2 | 2013 | 7 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2008 | 7913 | 0.050 |
Why?
|
| Vibrio cholerae | 1 | 1987 | 806 | 0.050 |
Why?
|
| Molecular Weight | 3 | 1991 | 2255 | 0.050 |
Why?
|
| Purkinje Fibers | 1 | 1999 | 32 | 0.050 |
Why?
|
| Female | 18 | 2019 | 380194 | 0.040 |
Why?
|
| Pyridines | 1 | 2011 | 2825 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2008 | 1855 | 0.040 |
Why?
|
| Receptors, Thyrotropin-Releasing Hormone | 1 | 1999 | 8 | 0.040 |
Why?
|
| Isotonic Solutions | 2 | 1991 | 119 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 1995 | 981 | 0.040 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1999 | 40 | 0.040 |
Why?
|
| Octanols | 2 | 1990 | 27 | 0.040 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1999 | 87 | 0.040 |
Why?
|
| Glycosaminoglycans | 2 | 2000 | 624 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10481 | 0.040 |
Why?
|
| Dihydropyridines | 1 | 1998 | 67 | 0.040 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1999 | 147 | 0.040 |
Why?
|
| Nicardipine | 1 | 1998 | 60 | 0.040 |
Why?
|
| Tritium | 5 | 1979 | 745 | 0.040 |
Why?
|
| Apoptosis | 1 | 2015 | 9727 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13284 | 0.040 |
Why?
|
| Presynaptic Terminals | 1 | 2000 | 302 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11366 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 1993 | 7880 | 0.040 |
Why?
|
| Cholesterol | 1 | 2007 | 2917 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2017 | 192 | 0.040 |
Why?
|
| Sheep | 1 | 2000 | 1437 | 0.040 |
Why?
|
| Anura | 4 | 1981 | 86 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2017 | 347 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2006 | 9146 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2000 | 597 | 0.040 |
Why?
|
| Fishes | 3 | 1976 | 569 | 0.040 |
Why?
|
| Membranes | 5 | 1993 | 173 | 0.040 |
Why?
|
| Somatostatin | 1 | 1999 | 459 | 0.040 |
Why?
|
| Cell Separation | 1 | 2002 | 1751 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 549 | 0.040 |
Why?
|
| Administration, Topical | 1 | 1998 | 690 | 0.040 |
Why?
|
| Ketamine | 1 | 2002 | 500 | 0.030 |
Why?
|
| Tachykinins | 2 | 1994 | 78 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 9959 | 0.030 |
Why?
|
| Indoles | 2 | 1994 | 1839 | 0.030 |
Why?
|
| Kidney | 1 | 2011 | 7186 | 0.030 |
Why?
|
| Amphibian Proteins | 2 | 1986 | 36 | 0.030 |
Why?
|
| Clone Cells | 1 | 1998 | 1692 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2002 | 1547 | 0.030 |
Why?
|
| Receptors, Drug | 3 | 1999 | 160 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1976 | 406 | 0.030 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1994 | 34 | 0.030 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1994 | 60 | 0.030 |
Why?
|
| Neurilemma | 1 | 1974 | 1 | 0.030 |
Why?
|
| Photochemistry | 1 | 1995 | 238 | 0.030 |
Why?
|
| Piperidines | 3 | 2002 | 1602 | 0.030 |
Why?
|
| Heating | 1 | 1995 | 97 | 0.030 |
Why?
|
| Nifedipine | 1 | 1994 | 226 | 0.030 |
Why?
|
| Cell Count | 2 | 2000 | 1856 | 0.030 |
Why?
|
| Tibial Nerve | 1 | 1994 | 50 | 0.030 |
Why?
|
| Thermosensing | 1 | 1994 | 56 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2001 | 1676 | 0.030 |
Why?
|
| Microcirculation | 1 | 1998 | 1286 | 0.030 |
Why?
|
| Collagen | 2 | 2000 | 2689 | 0.030 |
Why?
|
| Carbenoxolone | 1 | 2013 | 10 | 0.030 |
Why?
|
| Astacoidea | 1 | 1993 | 14 | 0.030 |
Why?
|
| Stilbenes | 1 | 1994 | 156 | 0.030 |
Why?
|
| PC12 Cells | 1 | 1993 | 330 | 0.030 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 1994 | 177 | 0.030 |
Why?
|
| Walking | 1 | 2020 | 1180 | 0.030 |
Why?
|
| Cockroaches | 1 | 1993 | 96 | 0.030 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1993 | 177 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 12072 | 0.030 |
Why?
|
| Permeability | 2 | 1991 | 738 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1681 | 0.030 |
Why?
|
| Heart Conduction System | 1 | 1978 | 1047 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2015 | 15295 | 0.030 |
Why?
|
| History, 20th Century | 2 | 2014 | 2740 | 0.030 |
Why?
|
| Chloroplasts | 1 | 1972 | 45 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 1995 | 514 | 0.030 |
Why?
|
| Analgesics, Opioid | 2 | 2018 | 3674 | 0.030 |
Why?
|
| Pyrrolidinones | 1 | 1992 | 117 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2013 | 212 | 0.030 |
Why?
|
| Dipeptides | 1 | 1994 | 409 | 0.030 |
Why?
|
| Bicarbonates | 1 | 1993 | 313 | 0.030 |
Why?
|
| Potassium Chloride | 1 | 1972 | 237 | 0.030 |
Why?
|
| Naphthalenes | 1 | 1992 | 194 | 0.030 |
Why?
|
| Polyethylene Glycols | 2 | 1987 | 1182 | 0.030 |
Why?
|
| Muscle, Smooth | 2 | 1994 | 934 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 20822 | 0.020 |
Why?
|
| Neurites | 1 | 1993 | 388 | 0.020 |
Why?
|
| Faculty | 1 | 2014 | 386 | 0.020 |
Why?
|
| Mollusca | 1 | 1991 | 40 | 0.020 |
Why?
|
| Affect | 1 | 2019 | 1476 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1991 | 326 | 0.020 |
Why?
|
| Carbamates | 1 | 1992 | 196 | 0.020 |
Why?
|
| Neuroblastoma | 2 | 2001 | 1226 | 0.020 |
Why?
|
| Guinea Pigs | 4 | 1994 | 1386 | 0.020 |
Why?
|
| Sirolimus | 1 | 2017 | 1564 | 0.020 |
Why?
|
| Pregnancy | 3 | 2019 | 29144 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 2126 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2019 | 4217 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1995 | 1060 | 0.020 |
Why?
|
| Incidence | 1 | 2008 | 20947 | 0.020 |
Why?
|
| Gait | 1 | 1995 | 793 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 1994 | 913 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1990 | 682 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39050 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 1572 | 0.020 |
Why?
|
| Sonication | 1 | 2009 | 83 | 0.020 |
Why?
|
| Iris | 3 | 1994 | 239 | 0.020 |
Why?
|
| Cell Physiological Phenomena | 1 | 1990 | 154 | 0.020 |
Why?
|
| 4-Aminobenzoic Acid | 1 | 1988 | 22 | 0.020 |
Why?
|
| Benzamides | 1 | 1994 | 1379 | 0.020 |
Why?
|
| Avidin | 1 | 1987 | 44 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1994 | 1504 | 0.020 |
Why?
|
| Rats, Inbred Lew | 2 | 2000 | 1162 | 0.020 |
Why?
|
| Etidocaine | 1 | 1987 | 3 | 0.020 |
Why?
|
| Pronase | 1 | 1987 | 32 | 0.020 |
Why?
|
| Acute Disease | 1 | 1998 | 7149 | 0.020 |
Why?
|
| Drosophila melanogaster | 4 | 1986 | 1708 | 0.020 |
Why?
|
| Aplysia | 1 | 1987 | 41 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2008 | 278 | 0.020 |
Why?
|
| Temperature | 2 | 1987 | 2206 | 0.020 |
Why?
|
| Hydrochloric Acid | 1 | 1987 | 76 | 0.020 |
Why?
|
| Electrophorus | 1 | 1986 | 5 | 0.020 |
Why?
|
| Electric Organ | 1 | 1986 | 54 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2007 | 420 | 0.020 |
Why?
|
| Oligopeptides | 2 | 2002 | 1189 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2000 | 1723 | 0.020 |
Why?
|
| Biotin | 1 | 1987 | 254 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8324 | 0.020 |
Why?
|
| Microsomes | 1 | 1986 | 257 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1994 | 1534 | 0.020 |
Why?
|
| Epithelium | 1 | 1991 | 1679 | 0.020 |
Why?
|
| Neurotoxins | 1 | 1987 | 237 | 0.020 |
Why?
|
| Ligands | 1 | 1993 | 3282 | 0.020 |
Why?
|
| Nickel | 1 | 1986 | 130 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 6314 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1987 | 596 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1988 | 494 | 0.020 |
Why?
|
| Heart Atria | 1 | 1991 | 1357 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1995 | 3760 | 0.020 |
Why?
|
| Glycols | 1 | 1984 | 59 | 0.020 |
Why?
|
| Muscle Contraction | 3 | 1994 | 1240 | 0.020 |
Why?
|
| Histamine Release | 2 | 1994 | 142 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 1994 | 13815 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2019 | 53288 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2013 | 1065 | 0.020 |
Why?
|
| Body Weight | 1 | 1995 | 4669 | 0.010 |
Why?
|
| Cations | 1 | 1984 | 232 | 0.010 |
Why?
|
| Sural Nerve | 1 | 1983 | 106 | 0.010 |
Why?
|
| beta-Endorphin | 1 | 2003 | 53 | 0.010 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2003 | 64 | 0.010 |
Why?
|
| Receptors, Opioid, delta | 1 | 2003 | 47 | 0.010 |
Why?
|
| Scorpions | 1 | 1982 | 4 | 0.010 |
Why?
|
| Glucose | 1 | 1995 | 4397 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1994 | 18111 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1983 | 305 | 0.010 |
Why?
|
| Drug Antagonism | 1 | 2002 | 50 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2007 | 1899 | 0.010 |
Why?
|
| Colon | 1 | 1991 | 1772 | 0.010 |
Why?
|
| Aged | 3 | 2019 | 163280 | 0.010 |
Why?
|
| Receptors, Opioid, mu | 1 | 2003 | 182 | 0.010 |
Why?
|
| Fura-2 | 1 | 2001 | 109 | 0.010 |
Why?
|
| Rana esculenta | 1 | 1981 | 23 | 0.010 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2003 | 144 | 0.010 |
Why?
|
| History, 19th Century | 1 | 1984 | 720 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 1981 | 34 | 0.010 |
Why?
|
| Fluorometry | 1 | 2001 | 106 | 0.010 |
Why?
|
| Homeostasis | 1 | 2013 | 3340 | 0.010 |
Why?
|
| Catalysis | 1 | 1983 | 761 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9313 | 0.010 |
Why?
|
| Bronchi | 1 | 1985 | 840 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15540 | 0.010 |
Why?
|
| Lithium | 2 | 1974 | 601 | 0.010 |
Why?
|
| Genes | 1 | 1985 | 1893 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 6489 | 0.010 |
Why?
|
| Middle Aged | 3 | 2019 | 213383 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 214055 | 0.010 |
Why?
|
| Carbon | 1 | 1984 | 687 | 0.010 |
Why?
|
| Axotomy | 1 | 2000 | 73 | 0.010 |
Why?
|
| Muscle Denervation | 1 | 1980 | 57 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 2000 | 77 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2001 | 898 | 0.010 |
Why?
|
| Barbiturates | 1 | 1980 | 114 | 0.010 |
Why?
|
| Urodela | 1 | 1979 | 17 | 0.010 |
Why?
|
| Phenols | 1 | 1983 | 497 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3701 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5078 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 14722 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1991 | 3690 | 0.010 |
Why?
|
| Diaphragm | 1 | 1980 | 349 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 1981 | 354 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29063 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 2050 | 0.010 |
Why?
|
| Optic Nerve | 1 | 1979 | 554 | 0.010 |
Why?
|
| Methods | 1 | 1976 | 1129 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2000 | 642 | 0.010 |
Why?
|
| Fishes, Poisonous | 1 | 1974 | 5 | 0.010 |
Why?
|
| Cations, Monovalent | 1 | 1974 | 25 | 0.010 |
Why?
|
| Receptors, Neurokinin-2 | 1 | 1994 | 24 | 0.010 |
Why?
|
| Heart Rate | 1 | 2006 | 4091 | 0.010 |
Why?
|
| Sodium Isotopes | 1 | 1974 | 11 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 9734 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1974 | 166 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1791 | 0.010 |
Why?
|
| Receptors, Neurokinin-3 | 1 | 1994 | 54 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 6756 | 0.010 |
Why?
|
| Thallium | 1 | 1973 | 101 | 0.010 |
Why?
|
| Vas Deferens | 1 | 1994 | 55 | 0.010 |
Why?
|
| Isoindoles | 1 | 1994 | 41 | 0.010 |
Why?
|
| Ouabain | 1 | 1974 | 264 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
| Peptide Fragments | 2 | 2002 | 5097 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1998 | 2124 | 0.010 |
Why?
|
| Chickens | 1 | 1995 | 865 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1974 | 499 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56430 | 0.010 |
Why?
|
| Valinomycin | 1 | 1972 | 19 | 0.010 |
Why?
|
| Radiation Effects | 1 | 1972 | 68 | 0.010 |
Why?
|
| Seizures | 1 | 1985 | 2859 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2000 | 1741 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 5892 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14557 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1972 | 313 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2001 | 2046 | 0.010 |
Why?
|
| Darkness | 1 | 1972 | 167 | 0.010 |
Why?
|
| Starch | 1 | 1972 | 81 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1993 | 411 | 0.010 |
Why?
|
| Electron Transport | 1 | 1972 | 211 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 85781 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1972 | 683 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2006 | 8554 | 0.010 |
Why?
|
| Acetates | 1 | 1972 | 311 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 1992 | 381 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2000 | 2925 | 0.010 |
Why?
|
| Aging | 1 | 1988 | 8664 | 0.010 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 1988 | 7 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 63114 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 1992 | 791 | 0.010 |
Why?
|
| Light | 1 | 1972 | 1374 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4931 | 0.000 |
Why?
|
| Fetus | 1 | 1992 | 1880 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1985 | 2186 | 0.000 |
Why?
|
| Phenol | 1 | 1983 | 43 | 0.000 |
Why?
|
| Cats | 1 | 1983 | 998 | 0.000 |
Why?
|
| Myocardial Ischemia | 1 | 1993 | 2148 | 0.000 |
Why?
|
| Species Specificity | 1 | 1985 | 2478 | 0.000 |
Why?
|
| Mutation | 1 | 1984 | 29786 | 0.000 |
Why?
|
| Subcellular Fractions | 1 | 1979 | 547 | 0.000 |
Why?
|
| Larva | 1 | 1980 | 519 | 0.000 |
Why?
|
| Neuromuscular Junction | 1 | 1980 | 398 | 0.000 |
Why?
|
| Genotype | 1 | 1985 | 12951 | 0.000 |
Why?
|
| Synapses | 1 | 1980 | 1728 | 0.000 |
Why?
|